[Drug prevention and therapy of acute gastroduodenal lesions (stress ulcers)]
- PMID: 1354910
[Drug prevention and therapy of acute gastroduodenal lesions (stress ulcers)]
Abstract
The incidence of acute lesions of the gastroduodenal mucosa is high in intensive care patients. A disturbed balance between aggressive and defensive factors is the cause of the mucosal damage. H2-receptor antagonists reduce gastric acidity, the most important aggressive agent, and are, therefore, still the drugs of choice for the prevention of stress ulcerations. Bleeding from mucosal lesions is the most common complication of stress ulcers. In addition to endoscopic and surgical techniques to stop bleeding, and prevent rebleeding, medical treatment with drugs like omeprazole have gained importance in recent years.
Similar articles
-
[H2 receptor antagonists in the therapy of peptic ulcer disease].Z Gastroenterol. 1987 Aug;25 Suppl 3:136-45. Z Gastroenterol. 1987. PMID: 2889298 German.
-
NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.J Clin Gastroenterol. 1990;12 Suppl 2:S13-20. J Clin Gastroenterol. 1990. PMID: 1978842 Review.
-
Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.Hepatogastroenterology. 2004 May-Jun;51(57):757-61. Hepatogastroenterology. 2004. PMID: 15143910 Clinical Trial.
-
Changing perspectives of H2 antagonists for stress ulcer prophylaxis.Crit Care Nurs Clin North Am. 1993 Jun;5(2):325-31. Crit Care Nurs Clin North Am. 1993. PMID: 8104424
-
Recent advances in the treatment of digestive diseases.J Int Med Res. 1989;17 Suppl 1:2A-8A. J Int Med Res. 1989. PMID: 2566540 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical